Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Payables (2024 - 2025)

Historic Payables for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $9.8 million.

  • Pyxis Oncology's Payables rose 10032.85% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 10032.85%. This contributed to the annual value of $4.9 million for FY2024, which is N/A changed from last year.
  • Per Pyxis Oncology's latest filing, its Payables stood at $9.8 million for Q3 2025, which was up 10032.85% from $9.4 million recorded in Q2 2025.
  • Pyxis Oncology's 5-year Payables high stood at $9.8 million for Q3 2025, and its period low was $2.3 million during Q1 2024.